Pernix Therapeutics Holdings, Inc. is a specialty pharmaceutical company focused on the sales, marketing and development of branded and generic pharmaceutical products primarily for the pediatric market. The Company’spediatric products, designed to improve the health and well-being of children, are focused in the specific areas of allergy, upper respiratory, including nasal, chest congestion and cough, antibiotics and dermatology, including head lice, and contact dermatitis.
Recent News
- 05/15/2012 PERNIX THERAPEUTICS INTRODUCES OMECLAMOX-PAK®, FIRST PRODUCT IN GASTROENTEROLOGY PORTFOLIO
- PERNIX THERAPEUTICS REPORTS FIRST QUARTER 2012 FINANCIAL RESULTS
- 05/09/2012 Pernix Therapeutics to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
| Founded in 1997, the Company is headquartered in The Woodlands, TX. Pernix Therapeutics Holdings, Inc. (PTX) is listed and publicly traded on the NYSE Amex. |




